Related Experiment Video
Updated: May 16, 2026

08:02
Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice
Published on: October 19, 2013
Mitochondrial DNA damage mediates hyperoxic dysmorphogenesis in rat fetal lung explants
Sarah A Gebb1, Ashley Decoux, Alicia Waggoner
1Department of Cell Biology and Neuroscience, University of South Alabama College of Medicine, Mobile, AL 36688, USA. sgebb@usouthal.edu
Neonatology
|November 17, 2012
Summary
Mitochondrial DNA (mtDNA) damage impairs preterm lung development under hyperoxia. Restoring mtDNA repair with endonuclease III (Endo III) fusion protein protected against lung injury, suggesting a therapeutic target.
Area of Science:
- Biomedical research
- Pulmonology
- Mitochondrial biology
Background:
- Mitochondrial DNA (mtDNA) damage is known to influence cellular responses to oxidant stress in cell cultures.
- However, the direct impact of mtDNA damage on the preterm lung remains understudied.
- Oxidant stress is a significant factor in neonatal lung injury.
Purpose of the Study:
- To investigate the link between hyperoxia-induced fetal lung dysmorphogenesis and mtDNA damage.
- To explore the potential of enhancing mtDNA repair as a therapeutic strategy for preterm lung dysplasia.
Main Methods:
- Assessed hyperoxia-induced mtDNA damage in fetal rat lung explants using quantitative alkaline gel electrophoresis.
- Utilized a fusion protein of endonuclease III (Endo III) to target and augment mtDNA repair within mitochondria.
- Evaluated fetal lung branching and surfactant protein C (SFPTC) expression.
Main Results:
- Hyperoxia exposure led to increased mtDNA damage in lung explants, correlating with impaired branching and reduced SFPTC mRNA levels.
- Treatment with the Endo III fusion protein successfully prevented hyperoxia-induced mtDNA damage.
- This intervention also restored normal lung branching and SFPTC mRNA expression.
Conclusions:
- Mitochondrial DNA plays a crucial role in governing fetal lung cellular responses to oxidant stress.
- Modulating mtDNA repair mechanisms presents a promising pharmacological approach for preventing hyperoxic lung injury in preterm neonates.
